Oliver Matthew J, Perl Jeff, McQuillan Rory, Blake Peter G, Jain Arsh K, McCormick Brendan, Yang Robert, Pirkle James L, Fissell Rachel B, Golper Thomas A, Shen Jenny I, Hu Susie L, Pellegrino Bethany, Liebman Scott E, Krishna Vinay N, Ravani Pietro, Clarke Alix, Quinn Robert R
Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, Ontario, Canada.
Perit Dial Int. 2020 Mar;40(2):185-192. doi: 10.1177/0896860819893813. Epub 2020 Jan 17.
Peritoneal dialysis (PD) is a more cost-effective therapy to treat kidney failure than in-center hemodialysis, but successful therapy requires a functioning PD catheter that causes minimal complications. In 2015, the North American Chapter of the International Society for Peritoneal Dialysis established the North American PD Catheter Registry to improve practices and patient outcomes following PD catheter insertion.
The objective of this study is to propose a methodology for defining insertion-related complications that lead to significant adverse events and report the risk of these complications among patients undergoing laparoscopic PD catheter insertion.
Patients undergoing laparoscopic PD catheter insertion were enrolled at 14 participating centers in Canada and the United States and followed using a Web-based registry. Insertion-related complications were defined as flow restriction, exit-site leak, or abdominal pain at any point during follow-up. We also included infections or bleeding within 30 days of insertion, and any immediate postoperative complications. Adverse events were categorized as PD never starting or termination of PD therapy, delay in the start of PD therapy or interruption of PD therapy, an emergency department visit or hospitalization, or need for invasive procedures. Cause-specific cumulative incidence functions were used to estimate risk.
Five hundred patients underwent laparoscopic PD catheter insertion between 10 November 2015 and 24 July 2018. The cumulative risk of insertion-related complications 6 months from the date of insertion that led to an adverse event was 24%. The risk of flow restriction, exit-site leak, and pain at 6 months was 10.2%, 5.7%, and 5.3%, respectively. PD was never started or terminated in 6.4% of patients due to an insertion-related complication. Leaks and flow restrictions were most likely to delay or interrupt PD therapy. Flow restrictions were the primary cause of invasive procedures. Fifty percent of the complications occurred before the start of PD therapy.
Insertion-related complications leading to significant adverse events following laparoscopic placement of PD catheters are common. Many complications occur before the start of PD. Insertion-related complications are an important area of focus for future research and quality improvement efforts.
与中心血液透析相比,腹膜透析(PD)是一种治疗肾衰竭更具成本效益的疗法,但成功的治疗需要一根功能良好且并发症最少的PD导管。2015年,国际腹膜透析学会北美分会设立了北美PD导管注册中心,以改善PD导管插入术后的操作及患者预后。
本研究的目的是提出一种定义导致严重不良事件的插入相关并发症的方法,并报告接受腹腔镜PD导管插入术患者中这些并发症的风险。
在加拿大和美国的14个参与中心招募接受腹腔镜PD导管插入术的患者,并通过基于网络的注册中心进行随访。插入相关并发症定义为随访期间任何时间出现的流量受限、出口部位渗漏或腹痛。我们还纳入了插入后30天内的感染或出血,以及任何术后即刻并发症。不良事件分为PD从未开始或PD治疗终止、PD治疗开始延迟或中断、急诊就诊或住院,或需要进行侵入性操作。使用特定病因累积发病率函数来估计风险。
2015年11月10日至2018年7月24日期间,500例患者接受了腹腔镜PD导管插入术。插入后6个月导致不良事件的插入相关并发症的累积风险为24%。6个月时流量受限、出口部位渗漏和疼痛的风险分别为10.2%、5.7%和5.3%。6.4%的患者因插入相关并发症导致PD从未开始或终止。渗漏和流量受限最有可能延迟或中断PD治疗。流量受限是进行侵入性操作的主要原因。50%的并发症发生在PD治疗开始之前。
腹腔镜放置PD导管后导致严重不良事件的插入相关并发症很常见。许多并发症发生在PD开始之前。插入相关并发症是未来研究和质量改进工作的一个重要关注领域。